The longest-running professional development program providing a holistic overview of the global drug development landscape and what it takes to bring a new drug or biologic to market.
Frequency: Annual
The longest-running professional development program providing a holistic overview of the global drug development landscape and what it takes to bring a new drug or biologic to market.
Frequency: Annual
2026 Tufts CSDD | 53rd Annual
The longest-running professional development program providing a holistic overview of the global drug development landscape and what it takes to bring a new drug or biologic to market.
Course Information TBD
ABOUT THIS COURSE:
The Tufts CSDD Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation is the longest-running professional development program in the biopharma space. Now in its 53rd year, this unique annual course prepares both new and experienced drug developers, regulators, policy makers, clinical investigators, and academic researchers for success in the life-sciences sector. Thousands of drug development professionals are alumni of this prestigious one-of-a-kind program. Top speakers from industry, academia, and the FDA share their expertise to create a highly stimulating and rewarding learning environment. For a complete list of topics and speakers, download the course brochure below.
The goal of the course is to provide a comprehensive overview of the pharmaceutical development process, focusing on topics vital to professionals involved in all aspects of bioinnovation. Participants include individuals employed by pharmaceutical and biotechnology companies, regulatory agencies, academic institutions, government entities, outsourcing providers, consultancies, investment firms, and other biopharmaceutical organizations involved in the research, development, regulation, and marketing of pharmaceutical products.
Clinical Pharmacology: Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.
Drug Development & Clinical Trials: Using a case-study approach, identify and solve practical, theoretical, and technical problems in human drug studies and analyze an experimental design for a new drug candidate.
Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the U.S., Europe, Japan & other pharmaceutical markets.
2026 Course Dates Coming Soon
Professionals working in or with the research-based biopharmaceutical industry
Physicians, clinical investigators, pharmacists, nurses, and academic researchers
Regulators and other government agencies involved in drug development
Outsourcing providers, consultants, investors, and analysts
Showcase the knowledge and skills you acquired from the program.
Share your learning achievements with clients, employers, and colleagues on online platforms and social media networks like LinkedIn, Facebook and X
The postgraduate program typically receives 125 - 150 participants. Many companies choose to send multiple staff to participate in the program under a special, discounted registration rate. If you would like to learn more about registering a group, please contact Sarah Wrobel at @email
Get More Information
Have questions or want to register? Fill out the below form to connect with our enrollment team